Facebook Twitter Instagram You Tube Pinterest LinkedIn RSS Podcasts Video Library Blog
 - Northwestern Memorial Hospital - Chicago

Pancreas / Islet Cell Transplant Clinical Trials

Islet Transplantation in Type 1 Diabetes

This study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episode. Learn more . . .


Single-Center, Open-Label Clinical Trial of the Efficacy of Peritransplant Administration of Deoxyspergualin in Promoting Restoration of Insulin Independence after Single-Donor Islet Cell Allotransplantation in Non-Uremic Type 1 Diabetic Recipients (CIT 03)

This study will assess the safety and efficacy of deoxyspergualin (DSG), an immunosuppressant drug, on post-transplant islet function in people with type 1 diabetes who have not responded to intensive insulin therapy. Learn more . . .


Islet Transplantation versus Intensive Insulin Therapy in Type 1 Diabetic Kidney Allograft Recipients (CIT 06)

The purpose of this study is to compare the safety and effectiveness of islet transplantation versus intensive insulin treatment (ITT) for treating type 1 diabetes in patients who have received kidney transplants. Learn more . . .


A Pilot Study of Islet Transplantation in Non-Uremic Diabetic Patients

The purpose of this study is to evaluate the safety and effectiveness of islet transplantation utilizing the Edmonton Protocol immunosuppressive regime. Learn more . . .


Advancing Islet Transplants for the Treatment of Type I Diabetes Care

Protocols are currently being finalized. Trials will be multi-center involving both Islet after Kidney Transplantation and Islet Cell Transplant alone.
Learn more . . .

Last UpdateFebruary 8, 2011
top